Overview Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia Status: Completed Trial end date: 2015-07-01 Target enrollment: Participant gender: Summary This study is to test escalating doses of carfilzomib in patients with relapsed acute myeloid and acute lymphoblastic leukemia. Phase: Phase 1 Details Lead Sponsor: Washington University School of Medicine